<p>Groups of BALB/c mice (<i>n</i> = 4) were challenged with a lethal dose of A/Philippines/2/82 (H3N2) virus at 4 weeks after 3rd vaccination. Survival rates (A) and body weight (B) were monitored for 14 days. Error bars indicates mean ± SEM. The data are representative out of two independent experiments.</p
<p><b>Copyright information:</b></p><p>Taken from "Roles of adjuvant and route of vaccination in ant...
(A-C) C57BL/6 mice were treated with (A and B) indicated dose of LAH31 IgG2c or PBS or (C) 5 mg/kg o...
<p>Mice were immunized as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0...
<p>Groups of 10 BALB/c mice were immunized i.m. with 2 µg sH5<sup>3</sup> either once (day 21) or tw...
<p>(A–B) Groups of vaccinated mice and a mock control were intranasally challenged with a lethal dos...
<p>Survival rate (A) and weight loss (B) were observed for 14 days after challenge in all intranasal...
<p>(A–B) At six months after prime-boost immunizations with M2 VLPs, mice (n = 5) were challenged wi...
<p>BALB/c mice (n = 10) were vaccinated with f88M2e2-16, f88-ctr, human M2eHBc or PBS three times in...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Kaplan-Meier survival curves (left), mean bodyweight change (middle) and median clinical score (r...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>Groups of ten BALB/c mice (3-week-old) were vaccinated with 5×10<sup>4</sup> PFU MVTT1, MVTT2 or ...
Groups of 10 Balb/c mice were immunized with Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, or Flg-4M2e fusion prot...
<div><p>(A) Three groups of mice were vaccinated with escalating doses of VV-hTAP1,2 (3e3 PFU, 3e4 P...
<p>Five-week-old female BALB/c mice (5 per group) were vaccinated with PBS, pgsA/<i>L. casei</i>, pg...
<p><b>Copyright information:</b></p><p>Taken from "Roles of adjuvant and route of vaccination in ant...
(A-C) C57BL/6 mice were treated with (A and B) indicated dose of LAH31 IgG2c or PBS or (C) 5 mg/kg o...
<p>Mice were immunized as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0...
<p>Groups of 10 BALB/c mice were immunized i.m. with 2 µg sH5<sup>3</sup> either once (day 21) or tw...
<p>(A–B) Groups of vaccinated mice and a mock control were intranasally challenged with a lethal dos...
<p>Survival rate (A) and weight loss (B) were observed for 14 days after challenge in all intranasal...
<p>(A–B) At six months after prime-boost immunizations with M2 VLPs, mice (n = 5) were challenged wi...
<p>BALB/c mice (n = 10) were vaccinated with f88M2e2-16, f88-ctr, human M2eHBc or PBS three times in...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Kaplan-Meier survival curves (left), mean bodyweight change (middle) and median clinical score (r...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>Groups of ten BALB/c mice (3-week-old) were vaccinated with 5×10<sup>4</sup> PFU MVTT1, MVTT2 or ...
Groups of 10 Balb/c mice were immunized with Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, or Flg-4M2e fusion prot...
<div><p>(A) Three groups of mice were vaccinated with escalating doses of VV-hTAP1,2 (3e3 PFU, 3e4 P...
<p>Five-week-old female BALB/c mice (5 per group) were vaccinated with PBS, pgsA/<i>L. casei</i>, pg...
<p><b>Copyright information:</b></p><p>Taken from "Roles of adjuvant and route of vaccination in ant...
(A-C) C57BL/6 mice were treated with (A and B) indicated dose of LAH31 IgG2c or PBS or (C) 5 mg/kg o...
<p>Mice were immunized as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0...